BioRestorative Therapies (BRTX) Gross Profit (2012 - 2026)
BioRestorative Therapies (BRTX) posted Gross Profit of $15,785 for Q1 2026, down 28.5% from $22,091 a year earlier and down 12.1% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Gross Profit (2012 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, Gross Profit at BioRestorative Therapies was $329,550, down 8.5% year-over-year; for FY2025, it was $335,856, down 9.9% from FY2024.
- In prior years, BioRestorative Therapies' Gross Profit was $372,928 in FY2024 (+155.8%) and $145,800 in FY2023.
- Quarterly Gross Profit has run from a low of $1,230 in Q3 2025 to a high of $294,571 in Q2 2025 over five years.
- On a year-over-year basis, Gross Profit has declined in each of the last three quarters, with growth averaging 96.7% over the last eight quarters.
- The strongest year-over-year quarter for Gross Profit in the past five years was Q3 2024, with growth of 601.5%; the weakest was Q3 2025, with a decline of 99.4%.
- According to Business Quant data, Gross Profit for the three prior quarters was $17,964 (Q4 2025), $1,230 (Q3 2025) and $294,571 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15,785.00 |
| Dec 31, 2025 | 17,964.00 |
| Sep 30, 2025 | 1,230.00 |
| Jun 30, 2025 | 294,571.00 |
| Mar 31, 2025 | 22,091.00 |
| Dec 31, 2024 | 39,961.00 |
| Sep 30, 2024 | 215,357.00 |
| Jun 30, 2024 | 82,610.00 |
| Mar 31, 2024 | 35,000.00 |
| Dec 31, 2023 | 19,300.00 |
| Sep 30, 2023 | 30,700.00 |
| Jun 30, 2023 | 64,500.00 |
| Dec 31, 2017 | 38,000.00 |
| Sep 30, 2017 | 16,000.00 |
| Jun 30, 2017 | 20,000.00 |
| Mar 31, 2017 | 7,000.00 |
| Dec 31, 2016 | 6,054.00 |
| Sep 30, 2016 | 5,000.00 |
| Jun 30, 2016 | 16,084.00 |
| Mar 31, 2016 | 9,115.00 |
API Access
BioRestorative Therapies Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();